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and ‡Thrombosis Research Section, Baylor College of Medicine, Houston, TexasABSTRACT Both type 2B and type 2M von Willebrand disease result in bleeding disorders; however, whereas type 2B has
increased binding affinity between platelet glycoprotein Iba and von Willebrand factor (vWF), type 2M has decreased binding
affinity between these twomolecules. We used R687E type 2B and G561S type 2M vWF-A1 mutations to study binding between
flowing platelets and insolubilized vWF mutants. We measured rolling velocities, mean stop times, and mean go times at 37C
using high-speed video microscopy. The rolling velocities for wt-wt interactions first decrease, reach a minimum, and then
increase with increasing shear stress, indicating a catch-slip transition. By changing the viscosity, we were able to quantify
the effects of force versus shear rate for rolling velocities and mean stop times. Platelet interactions with loss-of-function
vWF-A1 retain the catch-slip bond transition seen in wt-wt interactions, but at a higher shear stress compared with the wt-wt
transition. The mean stop time for all vWF-A1 molecules reveals catch-slip transitions at different shear stresses (gain-of-func-
tion vWF-A1 < wt vWF-A1< loss-of-function vWF-A1). The shift in the catch-slip transition may indicate changes in how the
different mutants become conformationally active, indicating different mechanisms leading to similar bleeding characteristics.INTRODUCTIONPlatelets mediate the homeostatic response to vascular
injuries. In arteries, this response is initiated specifically
by platelet receptor glycoprotein Iba (GPIba) tethering to
von Willebrand factor (vWF) on exposed subendothelium.
Platelet GPIba interacts with vWF to initiate rolling interac-
tions that are the first step in the formation of a hemostatic
plug at a site of vascular injury. After this initial step, plate-
lets activate, firmly adhere via the GPIIb/IIIa integrin, and
aggregate to form a plug and stop bleeding (1). Mutations
in either vWF or GPIba can disrupt this first step in hemo-
stasis, resulting in the bleeding disorders von Willebrand
disease (VWD) or platelet type VWD (pt-VWD), respec-
tively (2). Disruption of the normal interactions between
these molecules can also lead to thrombosis, as seen in
thrombotic thrombocytopenic purpura (3).
vWF is the largest soluble plasma protein and is found
both in the bulk fluid in its soluble form and in the subendo-
thelial matrix. At high shear stress, vWF binds to exposed
subendothelial matrix components and functions to bridge
exposed subendothelial collagens and circulating platelets
(4). vWF is a multimeric glycoprotein found in the plasma
as a globular protein consisting of a repeating vWF dimer
with a total molecular mass ranging from 500 to
20,000 kDa (5). A single vWF monomer contains 2050
amino acids and consists of 11 domains (D0-D3-A1-A2-
A3-D4-B1-B2-B3-C1-C2). The A1 domain specifically
binds platelet GPIba (6), collagens I and III (7,8), and
collagen IV (9), whereas the A3 domain participates in
collagen I and III binding (9–12), and the A2 domainSubmitted July 12, 2010, and accepted for publication November 19, 2010.
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(13). Crystal structures suggest that the b-switch (cystine
loop) and b-finger (N-terminus) strands of GPIba bind
directly to vWF-A1, whereupon the region between residues
227 and 241 at the C-terminus undergoes a conformational
change (14). Most gain-of-function (GOF) vWF-A1 muta-
tions are located on the A1 surface of the molecule contain-
ing its N- and C-termini, whereas loss-of-function (LOF)
vWF-A1 mutations are either located on the A1 surface
that is the upper face of the domain or buried inside the
A1 structure. These mutations do not directly interact with
GPIba, so it is thought that the mutations result in changes
that are propagated through the vWF-A1 structure to the
binding site with GPIba (15).
Evidence suggests that mutations in either vWF or GPIba
may lead to abnormal interactions between platelet GPIba
and soluble vWF. It is believed that in type 2B VWD,
increased aggregation of platelets with soluble vWF leads
to bleeding due to clearance of these aggregates or to
a lack of unbound GPIba receptors to interact at sites of
vascular injury. We recently showed that a catch bond
governs binding between platelet GPIba and vWF-A1 at
low shear stresses for interactions at room temperature
(16). Under normal conditions, wt-wt catch-bond interac-
tions prevent platelet aggregate formation, whereas type
2B VWD GOF mutations form platelet aggregates with
soluble vWF in bulk flow at lower shear stresses.
VWD type 2M LOF mutations in vWF show decreased
binding affinity resulting in increased rolling velocities
and off-rates. These types of mutations are characterized
by defective ristocetin binding and normal botrocetin
binding. Type 2M mutant G561S shows decreased ristocetin
binding and a normal multimerization pattern (17). It isdoi: 10.1016/j.bpj.2010.11.084
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the vWF molecule from undergoing a conformational
change that allows GPIba binding (7). Atomic force micros-
copy (AFM) experiments using type 2M mutations in vWF-
A1 showed that LOF G561S vWF-A1 binding to GPIba
results in a catch bond, with a transition to a slip bond at
higher force (18). It should be noted that the G1324S
mutation referred to by some authors (16,18) is the same
as the G561S mutation used in this work. However, the
tether-bond behavior of type 2M VWD-causing mutations
under conditions of flow remains largely unknown.
In this study, we measured rolling interactions to gain
insight into bonding behavior. It has been established that
cell rolling is predominantly mediated by the dissociation
rate of the bonds that are formed and broken during rolling
motions (19–21). Bond dissociation under flow is used to
determine the bond lifetime, which is inversely proportional
to the dissociation rate. We observed a decrease in rolling
velocity with increasing wall shear stress, suggesting
that the bond lifetime increases (or that the dissociation
rate decreases) with increasing force, indicative of a catch
bond. Conversely, the observation that the cell rolling
velocity increases with increasing shear stress likely
indicates that the bond lifetime is decreasing, or that the
dissociation rate is increasing, which is indicative of a slip
bond. We use the term ‘‘catch-slip’’ to describe these indi-
rect bonding measurements of rolling interactions, where
it is likely that catch and slip bonds are present, rather
than to indicate that catch and slip bonds were directly
measured. These types of catch-slip biphasic transitions
have previously been observed in selectins and E. coli
(20,22,23), as well as in mathematical models of adhesive
behavior (24,25).
To investigate the mechanics of the tether bond, we
captured interactions at 250 frames per second and con-
ducted a frame-by-frame analysis of these interactions.
The steps in binding of a single tether were analyzed and
characterized in stages as either a ‘‘stop’’ or a ‘‘go’’, as
described previously for selectin rolling interactions (20).
We analyzed the binding behavior between platelet GPIba
and vWF wt and mutant variations to better understand
how the changes seen in mutants associated with VWD
occur at the tether-bond level. We show that the rolling
velocity and bonding behavior provide insight into how
GPIba and vWF regulate rolling, and demonstrate for the
first time (to our knowledge) that platelets rolling on GOF
R687E vWF-A1 or LOF G561S vWF-A1 molecules retain
the catch-slip bond transition we previously observed for
wt-wt interactions (16). Based on the mean stop times
obtained under physiological fluid shear stress, we conclude
that the catch-slip transition for platelets interacting with
GOF R687E vWF-A1 occurs at a lower shear stress than
for wt-wt interactions, which occur at a still lower shear
stress than for LOF G561S vWF-A1 interactions (GOF
vWF-A1 < wt vWF-A1 < LOF vWF-A1). Taken together,these data provide information about the GPIba-vWF tether
bond and the differences that exist between LOF and GOF
mutations in vWF-A1, and hence between type 2M and
type 2B VWD.MATERIALS AND METHODS
Proteins and antibodies
Recombinant vWF-A1molecules (wt,R687E,G561S) andwt vWF-A1A2A3
molecules were produced as previously described (7,26,27). Whole vWF
was purchased from Calbiochem (San Diego, CA).Platelet isolation
Whole blood was drawn from healthy volunteers according to an approved
institutional review board procedure, and all volunteers gave written,
informed consent. Whole blood was drawn into citrate buffer (25 g sodium
citrate, 8 g citric acid, 500 mL H2O) containing 2 mM prostaglandin E-1.
The blood was centrifuged at 150 g for 15 min at room temperature.
The supernatant (platelet-rich plasma) was removed and mixed with acid
citrate dextrose buffer (6.25 g sodium citrate, 2 H2O, 3.1 g citric acid
anhydrous, 3.4 g D-glucose in 250 mL H2O), 10% by volume, and centri-
fuged at 900 g for 5 min at room temperature. The pellet was suspended in
Hepes-Tyrode buffer, and platelets were counted with a hemocytometer.
The platelet suspension was then diluted to 1  108 platelets per milliliter
in Hepes-Tyrode buffer for flow assays.Measurement of viscosity
The viscosity of the platelet suspension buffer was measured at 37C with
the use of an Ostwald dripping viscometer as previously described (20).
In some experiments, 6% Ficoll (MW 400, w/v; Sigma, St. Louis, MO)
was added to increase the viscosity 1.8-fold compared with buffer alone.Preparation of vWF molecule-coated surfaces
The flow-chamber surface was a 35 mm tissue culture dish coated with
vWF-A1 molecules (wt at 100 mg/mL, R687E at 100 mg/mL, or G561S
at 200 mg/mL), wt vWF-A1A2A3 (at 100 mg/mL), or whole vWFmolecules
(at 50 mg/mL). The dish was coated with 20 mL of vWF molecule and
incubated overnight at 4C. The surface was rinsed with phosphate-buffered
saline and blocked with 20 mL of 1% human serum albumin for 2 h at room
temperature, and then rinsed again with phosphate-buffered saline. The
prepared dish was brought to 37C and used as the lower surface for the
flow chamber.Flow-chamber assay
A parallel platelet flow chamber (GlycoTech, Gaithersburg, MD) was used
to apply shear stress to platelets interacting with the vWF-coated surface.
Platelets were perfused through the flow chamber with a syringe pump
(Harvard Apparatus, Holliston, MA). Interactions were visualized using
an inverted-stage phase-contrast microscope (DIAPHOT-TMD, X-20 or
X-10 phase objective and X-5 projection lens; Nikon, Garden City, NY).
The flow chamber was maintained at 37C by means of an air curtain
surrounding the microscope. Images were captured at 250 fps directly
to a computer using a high-speed video camera and Phantom 640 software
(Phantom V4.2; Vision Research, Wayne, NJ). Images were analyzed post
experiment using the Track Object module in Metamorph Offline software
(Molecular Devices, Sunnyvale, CA).Biophysical Journal 100(2) 304–312
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parameters
The rolling velocities (mm/s) were calculated as the total distance traveled
in 1 s. Each velocity represents an average of tens to hundreds of cells. The
freestream velocities were measured from platelets flowing over surfaces
coated with 1% HSA. The rolling step parameters were determined as
described previously (20) from video taken at 250 fps. These interactions
were classified as stop or go events based on whether a cell was accelerating
or decelerating in each frame relative to the previous frame. A cell that was
classified as accelerating was considered to be in a go phase, whereas a cell
with no acceleration or deceleration was considered to be stopped. Rolling
parameters were evaluated on an event basis rather than on a cell basis, as
described previously (20). In these cases, data points represent hundreds
and in some cases thousands of events, which in turn may result in error
bars that are not visible in the figures presented.Statistical analysis
We analyzed each data set using a one-way analysis of variance followed
by a t-test to determine whether neighboring data points were significantly
different from each other. To determine which pairs were significantlyBiophysical Journal 100(2) 304–312different for neighboring values of shear stress, we performed t-tests for
adjacent data points. All of the catch-slip transition values are statistically
significantly different from the data points for one shear stress higher and
one shear stress lower than the shear stress at which the catch-slip transition
occurs.RESULTS
Rolling velocities for platelets interacting
with vWF molecules
Platelet rolling velocities were calculated for interactions
of platelets with wt vWF-A1 (Fig. 1 A), GOF R687E
vWF-A1 (Fig. 1 B), LOF G561S vWF-A1 (Fig. 1 C), wt
vWF-A1A2A3 (Fig. 1 D), or whole vWF (Fig. 1 E).
Fig. 1 B includes the freestream velocities of platelets flow-
ing over 1% HSA, which are higher than the velocities
of rolling platelets. Platelets interacting with all vWF
molecules display a catch-slip transition, with the rolling
velocity first decreasing at lower shear stresses and thenFIGURE 1 Rolling velocities of platelets on
various forms of vWF molecule: (A) wt vWF-A1
(n ¼ 14–256), (B) GOF R687E vWF-A1 (n ¼
12–353), (C) LOF G561S vWF-A1 (n ¼ 23–98),
(D) wt vWF-A1A2A3 (n ¼ 10–36), and (E) wt
whole vWF (n ¼ 44–277). Because there is
decreased association between platelets and LOF
G561S vWF-A1 (C), fewer interactions occur at
all shear stresses, and none occur at the highest
shear stresses measured for other vWF molecules.
Measured freestream velocities of platelets
perfused across 1% HSA (D) are plotted in B to
show that the rolling velocity of platelets rolling
on GOF R687E vWF-A1 is less than the freestream
values. Data represent the mean 5 SE of rolling
platelets. Each catch-slip transition is statistically
significant with p < 0.05.
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The minimum rolling velocities were similar for all wt vWF
molecules and LOF G561S vWF-A1 (Fig. 1, A and C–E).
The catch-slip transition occurs for wt vWF-A1 (Fig. 1 A),
whole vWF (Fig. 1 E), and LOF G561S vWF-A1 (Fig. 1
C) at 16 dyn/cm2, whereas the transition for wt vWF
A1A2A3 (Fig. 1 D) occurs at 8 dyn/cm2 and the transition
for GOF R687E vWF-A1 (Fig. 1 B) occurs at 4 dyn/cm2.Effects of fluid viscosity on rolling velocities
in the wt vWF-A1 domain
Purified platelet-rich plasma with or without 6% Ficoll was
perfused across a wt vWF-A1-coated coverslip (100 mg/mL)
at 37C, as shown in Fig. 2. The results are plotted against
both shear rate (Fig. 2 A) and shear stress (Fig. 2 B). As
can be seen in the figure, there is an increase in shear stress
by a factor of 1.8 at a given shear rate for samples containing
6% Ficoll. When the rolling velocities are plotted as a func-
tion of shear rate (Fig. 2 A), the curves do not align.
However, when they are plotted as a function of shear stress
(Fig. 2 B), the curves align. These results show that rolling
interactions depend on the shear stress applied to the bond.FIGURE 2 Effects of viscosity on rolling velocity for (A) shear rate (n ¼
14–256) and (B) shear stress (n ¼ 10–112) for platelets rolling on wt vWF-
A1. Data represent the mean5 SE. Each catch-slip transition is statistically
significant with p < 0.05.Therefore, these data suggest that the bonding mechanism
depends on force rather than transport.Catch-slip transition shear stress varies
depending on the vWF-A1 molecule
Interactions of platelets rolling on vWF-A1 molecules were
characterized frame by frame as stop or go motions, and
rolling interactions were measured at 250 fps. Fig. 3 shows
the mean stop time data, i.e., the average time a cell spends
in the stop phase during a 1-s interval. For all vWF-A1
molecules, the mean stop time first increases and then
decreases as the shear stress and hence the force on the
bond increases. The catch-slip transition for GOF R687E
vWF-A1 (2 dyn/cm2; Fig. 3 B) is decreased compared
with that of wt vWF-A1 (16 dyn/cm2; Fig. 3 A). However,
this transition for LOF G561S vWF-A1 (32 dyn/cm2;
Fig. 3 C) occurs at an increased shear stress compared
with that of wt vWF-A1 molecule (Fig. 3 A).Effects of viscosity on the mean stop times
for platelets rolling on wt vWF-A1
Purified platelet-rich plasma with or without 6% Ficoll was
perfused across a wt vWF-A1-coated coverslip (100 mg/mL),
as shown in Fig. 4. The results are plotted against both shear
rate (Fig. 4 A) and shear stress (Fig. 4 B). The viscosity at a
given shear rate was increased by a factor of 1.8 by the
addition of 6% Ficoll. The curves do not align when plotted
against shear rate (Fig. 4 A), but do align when plotted as a
function of shear stress (Fig. 4 B). This alignment with shear
stress suggests that bond force governs mean stop time
interactions, as opposed to a transport-dependent bonding
mechanism.Mean stop time regulates platelets rolling
on wt vWF-A1 molecules
Purified platelet-rich plasma with or without 6% Ficoll was
perfused across a wt vWF-A1 coated coverslip (100 mg/mL)
at 37C. The average amount of time a cell spent in either the
stop or the go phase over a 1-s interval was calculated from
rolling data. Fig. 5 shows that the mean go time is constant
when compared with the mean stop time. Furthermore, the
mean go time is constant and less than the mean stop time
for all shear stresses investigated. These data indicate that
the mean go time is unaffected by the shear stress. Further,
because the mean stop time displays biphasic behavior with
longer durations, the data suggest that the mean stop time is
a controlling parameter for rolling interactions.DISCUSSION
Differences are observed in the bonding interactions
between GPIba and vWF molecules when we compare wtBiophysical Journal 100(2) 304–312
FIGURE 3 Mean stop times of platelets rolling on vWF-A1 molecules:
(A) wt vWF-A1 (n ¼ 14–256), (B) GOF R687E vWF-A1 (n ¼ 5–104),
and (C) LOF G561S vWF-A1 (n ¼ 11–382). Data represent the mean 5
SE. Each catch-slip transition is statistically significant with p < 0.05.
FIGURE 4 Effects of viscosity on the mean stop times of platelets on
wt vWF-A1 molecules: (A) shear rate (n ¼ 14–256) and (B) shear stress
(n ¼ 10–112). Data represent the mean 5 SE. Each catch-slip transition
is statistically significant with p < 0.05.
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and 2B VWD. The type 2M mutation used in these studies,
G561S, occurs naturally and is characterized by decreased
platelet binding in the presence of ristocetin (LOF), as
well as by a normal multimer pattern and normal number
of vWF antigens (17). The type 2B mutation used in these
studies, R687E, is characterized by enhanced platelet
binding with ristocetin (GOF) (28,29).Biophysical Journal 100(2) 304–312We previously showed that biphasic catch-slip bonds
govern wt-wt interactions, demonstrating that this bond is
force-dependent, and therefore that force plays an important
role in the bonding behavior between GPIba and vWF
molecules. However, the same mechanism was not seen
for wt GPIb-type 2B VWD interactions, in which the catch
bond behavior was absent (16). In this work we obtained
functional evidence for catch-slip bonds by observing
GPIba-vWF rolling interactions. We show that platelet wt
vWF-A1 interactions have a transition from a catch to
a slip bond (Fig. 1 A) at physiological temperatures. Further,
we report the novel (to our knowledge) observation that
platelet-GOF and platelet-LOF interactions under fluid
forces retain the catch-slip transition (Fig. 3, B and C),
but these transitions occur at lower and higher shear
stresses, respectively, than seen in wt-wt interactions
(Fig. 3, A–C). For the GOF R687E vWF-A1 mutation, our
data differ from previously reported results that showed
a pure slip bond (16). It may be that these differences can
be attributed to the difficulty of obtaining data at the lowest
shear stresses studied. It is also possible that the differences
in temperatures at which the experiments were conducted
FIGURE 5 Effect of shear stress on the mean stop time and mean go time
for platelet rolling interactions with wt vWF-A1 molecules: (A) 0% Ficoll
(n ¼ 14–256) and (B) 6% Ficoll (n ¼ 10–112). Data represent the mean5
SE. Each catch-slip transition is statistically significant with p < 0.05.
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Yago and colleagues (16)) are responsible for the differ-
ences observed, given that bond kinetics can be affected
by temperature.
Our data show that at physiological temperatures, GOF
and LOF mutations each differ from wt vWF-A1, but in
unique ways (Figs. 1, A–C, and 3). These data show that
rolling velocity interactions with each wt, GOF, and LOF
vWF-A1 molecules have a catch-slip bond (Fig. 1, A–C).
Further differences were seen in the mean stop time data
(Fig. 3), in that the catch-slip transition was seen for all three
types of vWF-A1 studied, but at different shear stresses.
Together, the rolling velocity and mean stop time data
suggest that although type 2M and type 2B VWD have
similar clinical manifestations, they employ different mech-
anisms for tether-bond dissociation.
To study differences in the tether bond, we first observed
the rolling velocities for three wt vWF molecules: vWF-A1
(Fig. 1 A), vWF-A1A2A3 (Fig. 1 D), and whole vWF
(Fig. 1 E). After completing the wt vWF molecule studies,we compared changes using GOF R687E vWF-A1 (Fig. 1 B)
and LOF G561S vWF-A1 (Fig. 1 C). First, we measured the
rolling velocities for wt vWF-A1A2A3 and whole vWF
(Fig. 1, D and E, respectively). In both cases the rolling
velocity of platelets interacting with the vWF molecule first
decreased and then increased with increasing shear stress.
For whole vWF, the rolling velocity did not increase as
dramatically as was seen for both wt vWF-A1 and wt
vWF-A1A2A3, which may be due to the presence of the
RGD sequence that is found in the whole vWF molecule
but not in the other molecules studied. It is likely that the
RGD sequence binds integrins that are present on the platelet
surface. During the experiments, the platelets were treated
with prostaglandin E-1 and citrate buffer to prevent signifi-
cant activation and thus decrease the likelihood that high-
affinity integrins would be present on the platelet surface,
since platelet activation is necessary for exposure of these
integrins. However, it is possible that some integrins were
activated at higher shear stresses, which would result in
bonds being formed for interactions with whole vWF that
were not present for the other vWF molecules used. Because
these interactions likely involve integrin bonds, the rolling
interactions result in the formation of some longer-lifetime
bonds, causing the platelets to move more slowly. However,
because the velocities do not drop to zero, there are not
enough integrin bonds to result in complete platelet arrest.
The minimum rolling velocity for platelets interacting with
whole vWF molecules occurred at 16 dyn/cm2, which is
the same minimum observed for both wt vWF-A1 and LOF
G561S vWF-A1 surfaces (Fig. 1, A and B, respectively). Of
interest, the minimum rolling velocity observed for platelet
interactions with wt vWF-A1A2A3 occurred at a shear stress
of 8 dyn/cm2 (Fig. 1 D). It was previously suggested that
a decrease in the catch-slip transition shear stress indicates
a destabilization of the vWF molecule used (18). The term
‘‘destabilization’’ refers to the idea that less shear stress is
required to result in adhesion, suggesting that the vWFmole-
cule has undergone a conformational change to become
active at a lower shear stress than it would have undergone
in its native wt form. Therefore, the fact that the transition
occurs at a lower shear stress for thewt-A1A2A3 vWFmole-
culemay suggest that this configuration of the vWFmolecule
is less stable thanwt vWF-A1 andwhole vWF. The catch-slip
transition for platelets interacting with GOF vWF-A1
occurred at an even lower shear stress: 4 dyn/cm2. This
lower transition suggests that the configuration of the GOF
vWF-A1 molecule may be less stable than the other vWF
molecules we studied.
We extended the rolling interactions to observe more
detailed motions of the platelets rolling on each vWF mole-
cule (Figs. 3–5). To quantify these interactions, each frame
was characterized as a stop or a go event based on whether
the cell was accelerating or decelerating in each frame
relative to the previous frame. These values are reported
here as mean stop times and mean go times. Previous studiesBiophysical Journal 100(2) 304–312
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rolling interactions (20). Although such data do not directly
measure single-bond behavior, they can be used to infer
information about bond lifetimes. For platelet-wt vWF-A1
interactions, we show that the mean stop time first increases
and then decreases with increasing shear stress, which is
similar to the rolling velocity transition shear stress shown
here in Fig. 1 A and reported previously (16). For both
rolling velocity and mean stop time data, the catch-slip tran-
sition occurs at 16 dyn/cm2 (Figs. 1 A and 3 A). Further, we
show that increasing the viscosity (and thus the force) at
a given shear rate results in curves that align when plotted
versus shear stress, but do not align when plotted versus
shear rate (Figs. 2 and 4). These data suggest that, overall,
rolling interactions depend on force rather than transport.
The mean stop time indicates the average amount of time
during a 1-s interval that the cell spends stopped. The
mean stop time data suggest how the off-rate or bond life-
time for each interaction is modulated, because this type
of measurement indicates how long the bond is stopped
before the platelet moves again. Our data, therefore, suggest
that the bond lifetime of wt-wt interactions increases and
then decreases with increasing applied force. Alternatively,
these data suggest that the off-rate decreases (longer life-
time) and then increases (shorter lifetime) as force is
increased. Further, the data show that both the overall roll-
ing velocities and more-detailed interactions (in this case,
the mean stop time) are governed by force.
To further study the changes introduced by mutations in
vWF, we calculated the mean stop times for each vWF-A1
mutant molecule in comparison with wt vWF-A1. Our
data show that the transition force for LOF G561S vWF-
A1 is greater than that for wt vWF-A1, which is greater
than that for GOF R687E vWF-A1 (Fig. 3). These data
suggest that greater force is required for the maximum
bond lifetime in G561S vWF-A1 compared with wt
vWF-A1, whereas less force is required for GOF R687E
vWF-A1 compared with wt vWF-A1. These data show
that the catch-slip transition seen for rolling velocity is
carried over to a parameter that describes a more specific
property of the bonding mechanism.
Recently, Auton et al. (18) studied the thermodynamic
stability of vWF-A1 wt and mutant molecules. They
produced single-molecule AFM data showing that the
catch-slip transition for bond lifetimes also exists for both
type 2M and type 2B mutants and wt vWF-A1. Further, their
AFM and thermodynamic data show that the transition for
GOF mutations occurs at lower forces in vWF-A1 compared
with wt vWF-A1, which occurs at lower forces than
observed for LOF mutations in vWF-A1. Our mean stop
time results (Fig. 4) are consistent with their data, suggest-
ing that the stability observed in AFM and thermodynamic
measurements can also be seen in the flow-chamber exper-
iments, in which the molecule pairs are subjected to a more
physiological environment.Biophysical Journal 100(2) 304–312We also studied the mean go times for wt-wt rolling inter-
actions, which represent the average amount of time the
platelets spent moving forward after a stop. Based on the
model used (20), the mean go time is the combination of
the cell first pivoting to break the previous bond and the
cell stretching the new trailing bond as it moves forward to
form the next bond. Thus, the observations made here can
be used to infer whether the rate of association plays a role
in the tether bond, but do not directly measure the on-rate.
The rolling step interactions show that the mean go time
for wt-wt interactions is constant when compared with the
mean stop time for wt-wt interactions (Fig. 5). Further, the
data show that the mean go time is less than the mean stop
time for all shear stresses. Together, these data suggest that
the mean stop time is likely the controlling parameter in
GPIba-vWF rolling interactions. Because the stop time
suggests information about how long a bond lasts (i.e., the
bond lifetime) and the go time suggests information about
how bonds are formed, the combined data suggest that the
bond lifetime regulates platelet interactions with the wt
vWF-A1 molecule when subjected to fluid shear stress.
Because the mean go time is constant relative to the mean
stop time, these data suggest that the time spent by the cell
moving forward will be unaffected by changes in fluid shear
stress when compared with changes in the time the cell
spends stopped. Because the mean stop time suggests
changes in the bond lifetime (regulated by force), these
observations can be extended to suggest that force mecha-
nisms, rather than transport mechanisms, regulate the
GPIba-vWF tether bond when subjected to fluid shear stress.
These observations, made over a range of shear stresses,
reveal the presence of catch-slip transitions at shear stresses
that may reflect changes in vWF structure not only for wt-wt
interactions but also for wt-LOF vWF-A1 (rolling and mean
stop time data) and wt-GOF vWF-A1 (mean stop time data)
interactions. Additional studies will lead to a greater under-
standing of how naturally occurring mutations in vWF result
in each type of VWD. The data shown here provide details
about the GPIba-vWF tether bond and show differences
among different types of mutations in the vWF molecule,
and hence between type 2M and type 2B VWDs. These
data may also explain why bleeding is seen for both GOF
and LOF mutations in vWF. For GOF type 2B VWD, there
are likely prolonged lifetimes for platelet interactions
with GOF R687E vWF-A1 at the lowest shear stresses.
This would result in platelet binding to soluble vWF,
effectively clearing platelets from the bulk fluid, and
consequently there would not be enough to interact at sites
of vascular injury. For LOF type 2M VWD mutations, there
is decreased adhesion between platelets and LOF vWF
mutants when they have an opportunity to bind, and the
catch-slip transition (i.e., the shear stress at which bonds
last for the longest time) is at a higher shear stress.
Kumar et al. (30) measured the tether frequency for LOF
and GOF mutations in the GPIba molecule, which may
GPIba-vWF Bonding in Type 2M and 2B VWD 311display trends similar to those of LOF and GOFmutations in
the vWF-A1 molecule. In their work, the tether frequencies
for LOF mutations were less than those for wt molecules,
which were less than those for GOF mutations, indicating
that fewer tethering events were occurring for the LOFmuta-
tion and morewere occurring for the GOFmutation. Further,
they observed that as shear stress increased, the tether
frequency for all molecules decreased, indicating fewer
tethering events. If similar behavior is occurring for muta-
tions in the vWF-A1 molecule, this, in addition to the data
shown here, may help explain bleeding in type 2M patients.
By becoming more stabilized at higher shear stresses
compared with wt vWF-A1 molecules, LOF vWF-A1 mole-
cules likely become conformationally active at shear
stresses where they are not able to bind platelets effectively
because of the decreased number of successful interactions
at these higher shear stresses. Further, the data shown in
Fig. 4 indicate that the magnitude of the mean stop time
at its maximum value is less for LOF vWF-A1 than for wt
vWF-A1. Together with the data of Kumar et al. (30), our
findings data suggest the occurrence of fewer events that
last for a shorter period of time, providing a possible expla-
nation for the decreased binding that is characteristic of type
2M VWD.
Because GOF mutations are less stable at a lower shear
stress than wt vWF-A1 molecules (i.e., more susceptible
to force than wt vWF-A1 at its normal transition shear
stress), it is likely that GOF vWF-A1 molecules become
conformationally active at these low shear stresses and are
able to participate in the enhanced binding that is character-
istic of type 2B VWD. Here we also see that the magnitude
of the maximum mean stop time for GOF vWF-A1 mole-
cules is less than that of wt vWF-A1. If the GOF vWF-A1
molecules behave similarly to the GOF GPIba molecules
studied by Kumar et al. (30), it is possible that an increased
number of interactions occur at the GOF transition shear
stress (i.e., increased tethering frequency), but these interac-
tions are more rapid, which could result an increased
number of adhesive events.
Together, these observations may explain why both type
2B and type 2M VWDs result in patient bleeding but have
different underlying mechanisms. Our determination of
the biomechanical and kinetic properties of wt and mutant
molecules elucidates the possible physiological mecha-
nisms inherent in interactions between GPIba and vWF,
and may lead to a better understanding of both type 2B
and type 2M VWD bleeding disorders.
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